- Differences in the Prognosis according to the Periods of Diagnosis in Ulcerative Colitis
-
Chae HB, Jung YS, Park DI, Lee CK, Huh KC, Shin JE, Kim JH, Kim YS, Jung Y, Jung SA, Song HJ, Jang HJ, Hong SN, Kim YH
- KMID: 2164419
- Korean J Gastroenterol.
- 2014 Aug;64(2):93-97.
- doi: 10.4166/kjg.2014.64.2.93
BACKGROUND/AIMS: Infliximab was approved for the treatment of ulcerative colitis (UC) in 2006 and has recently been used as rescue therapy in steroid-refractory UC. The aim of this study was... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Crohn's Disease Showing Favorable Response to Induction and Maintenance Therapy with Methotrexate after Failure of Anti-tumor Necrosis Factor Therapy
-
Choi J, Yun GW, Park YM, Kim JH, Youn YH, Park H, Park JJ
- KMID: 2373347
- Korean J Gastroenterol.
- 2015 Oct;66(4):231-236.
- doi: 10.4166/kjg.2015.66.4.231
Thanks to the introduction of immumomodulators and biologics, therapeutic approaches in Crohn's disease have changed significantly during the past decade. Although new biologic therapy has dramatically improved the treatment of... -
- CITED
-
- Close
- SHARE
-
- Close
- Factors Contributing to the Preference of Korean Patients with Crohn's Disease When Selecting an Anti-Tumor Necrosis Factor Agent (CHOICE Study)
-
Kim ES, Kim KO, Jang BI, Lee CK, Kim HJ, Lee KM, Kim YS, Eun CS, Jung SA, Yang SK, Lee J, Kim TO, Jung Y, Seo GS, Yoon SM, the IBD Study Group of the Korean Association for the Study of the Intestinal Diseases (KASID)
- KMID: 2411966
- Gut Liver.
- 2016 May;10(3):391-398.
- doi: 10.5009/gnl15126
BACKGROUND/AIMS: Two comparable anti-tumor necrosis factor (TNF) agents with different routes of administration (intravenous [iv] infliximab [IFX] vs subcutaneous [sc] adalimumab [ADA]) are available for patients with Crohn's disease (CD)... -
- CITED
-
- Close
- SHARE
-
- Close
- Diffusion-Weighted MR Enterography to Monitor Bowel Inflammation after Medical Therapy in Crohn's Disease: A Prospective Longitudinal Study
-
Huh J, Kim KJ, Park SH, Park SH, Yang SK, Ye BD, Park SH, Han K, Kim AY
- KMID: 2468130
- Korean J Radiol.
- 2017 Feb;18(1):162-172.
- doi: 10.3348/kjr.2017.18.1.162
OBJECTIVE: To prospectively evaluate the performance of diffusion-weighted imaging (DWI) to monitor bowel inflammation after medical therapy for Crohn's disease (CD). MATERIALS AND METHODS: Before and following 1–2 years of medical... -
- CITED
-
- Close
- SHARE
-
- Close
